Extendicare Inc. · TSX:EXE

Extendicare — Q4 2025 Earnings Presentation

19 slides from Extendicare's earnings presentation, Feb 27, 2026

  1. Slide 1: Growing Together

    Cover Option o/s new photo Growing Together Q4 2025 Conference Call February 27, 2026

  2. Slide 2: Forward-looking statements and non-GAAP measures

    Forward-looking statements and non-GAAP measures Forward-looking Statements LTC Limited Partnership and its affiliates of Extendicare to differ materially from those (“collectively, Axium”) and two limited partnership expressed or implied in the statements. This presentation contains forward-looking

  3. Slide 3: Q4 highlights

    Q4 highlights Adjusted EBITDA, excluding out-of-period items, increased by 36.4% to $45.6M Financial highlights Q4 Q4 Adjusted EBITDA Operational highlights 2025 2024 Reported $49.5M $39.7M +24.6% 27.3% YoY increase in home health care ADV; 15.3% organic growth plus 3,700 ADV contribution Excluding

  4. Slide 4: CBI Home Health acquisition

    CBI Home Health acquisition Creating a national home health care platform • Advances Extendicare’s services focused growth strategy Accretion • CBI Home Health is highly complementary to ParaMed, with the potential for significant synergies +15% (1) +9% (1) AFFO per share Earnings per share • Enhanc

  5. Slide 5: Building for the future

    Building for the future 1,728 beds under construction across 7 homes • Commenced construction on 320-bed home in Sudbury; expected to open Q1 2029. Seeking regulatory approval to complete the sale of the project into the Axium JV in the coming weeks Estimated • Subsequent to year end sold the vacate

  6. Slide 6: Financial Review

    Financial :{-\"/(-\"\" Q4 2025 888 |Aee

  7. Slide 7: Consolidated results

    Consolidated results Q4 2025 • Out-of-period items recognized in Q4 2025(1) consisted of WSIB rebates received in LTC and home health, partially offset by retro wage Q4 2025 vs Q4 2024 adjustments in LTC - a net favourable impact to NOI of $3.9M compared Reported to a $6.3M favourable impact to NOI

  8. Slide 8: Home health care

    Home health care Strong organic growth in ADV up 15.3% from Q4 2024 ADV and Adjusted NOI Margin %(1) 13.2% 16% 13.5% 13.6% 40,000 12.6% 14% 11.3% 10.4% 10.3% 38,000 • Q4 revenue up $49.7M; up $54.1M excluding out-of- 12% 10% 8.3% 36,000 34,000 period items(2), driven by $26.6M contribution from Clos

  9. Slide 9: Long-term care

    Long-term care Growth driven by the LTC acquisition and funding increases NOI Margin % (1) 15% • Q4 revenue up $24.4M; up $26.3M(2) excluding out-of- 11.8% period items, reflecting the contribution from the 9-home LTC 10% 11.4% 11.6% 11.3% 10.0% 10.9% acquisition (+$35.2M), funding increases and tim

  10. Slide 10: Managed services Extendicare Assist and SGP

    Managed services Extendicare Assist and SGP 5.0% organic growth in SGP client base offset by loss of Assist management contracts related to Revera’s sale of its Class C LTC homes SGP (3rd party and JV beds) 175,000 • Q4 revenue down $3.6M; largely driven by Revera’s 150,000 sale of its 30 Class C LT

  11. Slide 11: Strong liquidity and credit metrics

    Strong liquidity and credit metrics $502M total liquidity at Q4-25 Debt Metrics(3) 7.4x 8.0x 8.1x As at December 31, 2025 6.5x 7.1x 34.1% 33.9% Available Long-term 33.0% 32.3% Long-term 32.1% 31.7% Cash Revolving debt(1) debt(1) 6.1x 30.4% Facility (including 15% JV share(2)) 5.3x 4.2x $348M $154M $

  12. Slide 12: Meeting the needs of a growing demographic

    Meeting the needs of a growing demographic Compelling growth opportunities in long-term care and home health care The number of Canadians aged 85+ will Building new LTC homes to address the double by 2036 and triple by 2051 rising demand for long-term care Canadian Population 85+ 3x • Seniors aged 8

  13. Slide 13: Appendix

    o/s new photos Appendix

  14. Slide 14: Adjustments to revenue, NOI, EBITDA and AFFO

    Adjustments to revenue, NOI, EBITDA and AFFO Three and twelve months ended December 31, 2025 • Q4 2025 impacted by net favourable out-of-period costs of $3.9M • LTC and home health care recognized workers’ compensation rebates Impact of out-of-period items on Revenue, NOI, Adjusted EBITDA and AFFO/b

  15. Slide 15: Adjusted NOI by division

    Adjusted NOI by division(1) Three and twelve months ended December 31, 2025 Long-term care NOI and margin(1) Home health care NOI and margin(1) Q4 Q4 YTD YTD Q4 Q4 YTD YTD 2025 2024 Change 2025 2024 Change 2025 2024 Change 2025 2024 Change $27.3M $22.3M +22.0% $96.8M $84.5M +14.5% $26.1M $14.9M +75.

  16. Slide 16: Services-focused growth

    Services-focused growth Services represented ~56% of adjusted NOI Direct care for seniors NOI contribution by segment(1) Home health care 2025 Adjusted NOI(1) $221.8M Long-term care Managed 59 Home 14.0M Home health care Long-term care health care $88.1M 39.7% services 16.7% $36.9M homes owned hours

  17. Slide 17: CBI Pro forma financial information and non-GAAP reconciliation

    CBI Pro forma financial information and non-GAAP reconciliation Reconciliation of pro forma net operating income to Adjusted EBITDA and pro forma net earnings to FFO and AFFO Pro Forma Consolidated Financial Information and non-GAAP reconciliation Notes: CBI Home Extendicare (1) Represents the conso

  18. Slide 18: Non-GAAP Financial Measures

    Non-GAAP Financial Measures Non-GAAP Financial Measures “Debt to GBV” is a supplementary financial measure and is defined as the This presentation makes reference to certain non-International Financial ratio of total debt to gross book value (GBV), where total debt consists of all Reporting Standard

  19. Slide 19: Slide 19

Extendicare — Q4 2025 Earnings Presentation on 6ix